We are a global family

PVRI Insights Survey

Tell us what’s working, what could be better, and what you’d like to see more of from PVRI. Your insight will directly inform our future priorities and help us better support you and your work in PH.

Take the survey

PVRI Digital Webinar Series

Our PVRI Digital Webinar Series alternates between 'Cutting Edge Innovation In Clinical & Experimental PH' and 'Living Legends in PH: History & Personal Perspectives' sessions. Don't miss out!

Find out more

Featured events

Living Legends: Stuart Rich, Northwestern University Feinberg School of Medicine

12 February 2026

Living Legend Stuart Rich shares insights from four decades of pioneering research that transformed the understanding and treatment of pulmonary hypertension, in conversation with Serpil Erzurum and Saad Kubba.

SAPH 2026

12 February 2026

SAPH2026 will gather leading clinicians and researchers in Jeddah to share new insights, advances, and best practice in pulmonary hypertension.

Pulmonary Hypertension Community Call — February

19 February 2026

PVRI's monthly PH Community Calls are free online, informal discussions on the latest developments in pulmonary hypertension.

Moderated by Katarina Zeder, Rodolfo Estrada, Joel James, Sandeep Sahay, Katrina Barry and Tatiana Kudryashova.

Do Travelers to High Altitude Need to Worry about their Blood Pressure?

10 March 2026

Part of the Hypoxia in pulmonary vascular research – altitude and beyond webinar series

Featured learning and research

Challenges of Developing Novel Therapies for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

This webinar brings together leading experts to explore the urgent need for new therapies in bronchopulmonary dysplasia-associated pulmonary hypertension. You’ll gain a clear overview of current care, key research gaps, and the real-world challenges of designing meaningful trials for preterm infants — all aimed at advancing treatment for this under-recognised condition.

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: A Comparative Study of Biomarkers and Clinical Indicators

A major consequence of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is pulmonary hypertension (PH), which raises morbidity and mortality rates. This study assessed biomarker profiles, clinical characteristics and diagnostic efficacy of important coagulation and inflammatory markers in AECOPD patients who have varying degrees of PH severity.

Beta-Alanine Supplementation Ameliorates Right Ventricular Remodeling Caused by Monocrotaline-Induced Pulmonary Hypertension

Pulmonary hypertension (PH) causes progressive pulmonary vascular resistance and right heart failure. We investigated whether beta-alanine (β-Ala) improves right ventricular (RV) remodeling and dysfunction in a monocrotaline (MCT)-induced PH rat model.

Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force

Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise testing (iCPET) and its potential to inform pathophysiology and therapeutic decision-making.

News

2025–26 IDDI Workstream & Task Forces Report published

An overview of the PVRI IDDI Workstreams and Task Forces 2026 Report, highlighting global collaboration and progress in PH research and care.

PVRI Insights Survey

We’ve launched the PVRI Insights Survey to better understand what’s working, what could be improved, and what our community needs most. Your feedback will directly inform PVRI’s future priorities and help us better support you and your work in PH.

Introducing PVRI’s Patient Engagement & Empowerment Series

PVRI has launched a new Patient Engagement & Empowerment series designed to support people living with pulmonary hypertension, their families, and carers. Explore 11 key themes with short videos and practical resources to help build confidence, understanding, and connection throughout the PH journey.

Nominations now open for PVRI Awards 2026

These annual awards are given in recognition of outstanding contributions to the field of pulmonary hypertension. They celebrate notable achievements made by special individuals across the world. The PVRI Lifetime Achievement Award 2025, the PVRI Achievement Awards 2025 and the PVRI Special Recognition Award will be presented at PVRI 2026 Dublin.